<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Clin Mol Hepatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Clin Mol Hepatol</journal-id>
      <journal-id journal-id-type="publisher-id">CMH</journal-id>
      <journal-title-group>
        <journal-title>Clinical and Molecular Hepatology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2287-2728</issn>
      <issn pub-type="epub">2287-285X</issn>
      <publisher>
        <publisher-name>The Korean Association for the Study of the Liver</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26157757</article-id>
      <article-id pub-id-type="pmc">4493363</article-id>
      <article-id pub-id-type="doi">10.3350/cmh.2015.21.2.183</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Liver Pathology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Cholangiolocellular carcinoma with satellite nodules showing intermediate differentiation</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Jung</surname>
            <given-names>Wonkyung</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Kim</surname>
            <given-names>Baek-hui</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
      </contrib-group>
      <aff id="A1">Department of Pathology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.</aff>
      <author-notes>
        <corresp>Corresponding author: Baek-hui Kim. Department of Pathology, Korea University Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul 152-703, Korea. Tel: +82-2-2626-3255, Fax: +82-2-2626-1486, <email>maelstrom@naver.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>6</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>26</day>
        <month>6</month>
        <year>2015</year>
      </pub-date>
      <volume>21</volume>
      <issue>2</issue>
      <fpage>183</fpage>
      <lpage>186</lpage>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2015 by The Korean Association for the Study of the Liver</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>Cholangiolocellular carcinoma</kwd>
        <kwd>Combined hepatocellular cholangiocarcinoma</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Cholangiolocellular carcinoma, a rare type of primary malignant tumor of liver, is thought to originate from cholangioles or canals of Hering, where hepatic progenitor or stem cells are located,<xref rid="B1" ref-type="bibr">1</xref><xref rid="B2" ref-type="bibr">2</xref> and has characteristic histologic features of tubular, cord-like and 'antler-like' pattern with marked fibrous stroma.<xref rid="B3" ref-type="bibr">3</xref> Cholangiolocellular carcinoma was previously classified as one type of intrahepatic cholangiocarcinoma. But now, on the basis of the concept that combined hepatocellular-cholangiocarcinoma is derived from hepatic progenitor cells, cholangiolocellular carcinoma is classified as combined hepatocellular-cholangiocarcinoma with stem-cell features in the latest version of the World Health Organization (WHO) classification of the digestive system 2010.<xref rid="B3" ref-type="bibr">3</xref> Because of its limited number of cases, its biologic behavior or clinical outcomes have not been fully understood.</p>
    </sec>
    <sec>
      <title>CASE SUMMARY</title>
      <p>A 62-year-old male presented with abdominal pain and dyspnea. He was a chronic alcoholic and had no positive markers for hepatitis virus. On physical examination, he showed epigastric tenderness. Initial serum aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase levels were 48 IU/L, 19 IU/L and 167 IU/L, respectively. Serum alpha-fetoprotein, carcinoembryonic antigen and carbohydrate antigen 19-9 levels were 4.9 ng/mL, 2.2 ng/mL and 12.1 U/mL, respectively. Abdominal computed tomography and magnetic resonance imaging showed a 5 cm-sized peripheral enhancing lesion with centripetal enhancement pattern, and multiple arterial enhancing nodules in right hepatic lobe. Under the impression of intrahepatic malignant tumor, he underwent a right lobectomy of liver.</p>
    </sec>
    <sec>
      <title>PATHOLOGICAL FINDINGS</title>
      <p>On gross examination, liver surface showed multiple protruding nodules. On serial section of the liver, there was a 5 cm-sized whitish firm and fibrotic mass and more than 10 multiple small satellite nodules with same consistency and color of the largest mass (<xref ref-type="fig" rid="F1">Fig. 1</xref>). Microscopically, the 5 cm-sized largest mass showed tumor cells arranged in tubular, cord-like and anastomosing histologic pattern, so called "antler-like" pattern with mild nuclear atypia in the marked fibrous stroma of which the typical findings of cholangiolocellular carcinoma (<xref ref-type="fig" rid="F2">Fig. 2</xref>). Most of other satellite nodules showed same histologic findings. But, there were two satellite nodules which revealed different histologic findings from other nodules. Tumor cells of these nodules had more abundant cytoplasm than other nodules, showed trabecular or cluster like structural pattern rather than tubular or antler-like pattern, and had scant intervening fibrous stroma. These histologic findings were intermediate differentiation between hepatocellular carcinoma and cholangiocarcinoma. On immunohistochemical stainings, the cells of typical cholangiolocellular carcinoma nodules were positive for keratin 19, but the tumor cells showing intermediate differentiation were negative for keratin 19. Both type cells were negative for hepatocyte paraffin 1 (HepPar-1) which is relatively specific marker for hepatocellular carcinomas and positive for epithelial cell adhesion molecule (EpCAM) which is used as stem/progenitor cell marker (<xref ref-type="fig" rid="F3">Fig. 3</xref>). Through these findings, the diagnosis of combined hepatocellular-cholangiocarcinoma with stem-cell features, cholangiolocellular type could be made.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Combined hepatocellular-cholangiocarcinoma, a rare primary malignant liver tumor, is composed of unequivocal, intimately mixed components of both hepatocellular carcinoma and cholangiocarcinoma.<xref rid="B3" ref-type="bibr">3</xref> Classical type of combined hepatocellular-cholangiocarcinoma contains both typical hepatocellular carcinoma and typical cholangiocarcinoma area.</p>
      <p>Combined hepatocellular-cholangiocarcinoma with stem cell feature is newly adopted in the latest WHO classification of the digestive system 2010. This category includes typical subtype, intermediate-cell subtype and cholangiolocellular subtype.<xref rid="B3" ref-type="bibr">3</xref> Typical subtype is characterized by mature appearing hepatocytes with peripheral cluster of small cells showing positive immunoreactivity for stem/progenitor cell markers.<xref rid="B3" ref-type="bibr">3</xref> Intermediate-cell subtype consists of tumor cells with features intermediate between hepatocytes and cholangiocytes characterized by small and oval-shaped tumor cells with scant cytoplasm and arranged in solid nests and strands within fibrotic stroma with marked desmoplasia.<xref rid="B3" ref-type="bibr">3</xref><xref rid="B4" ref-type="bibr">4</xref> Cholangiolocellular type is characterized by tubular, cord-like, anastomosing pattern, the so-called "antler-like" pattern, mild nuclear pleomorphism, and marked fibrous stroma.<xref rid="B3" ref-type="bibr">3</xref><xref rid="B5" ref-type="bibr">5</xref></p>
      <p>This case showed multiple masses with mainly typical histologic findings of cholangiolocellular carcinoma with tumor cells arranged in tubular, cord-like and "antler-like" pattern in the marked fibrous stroma, and small portion of stem cell-like intermediate differentiation. The immunohistochemical stain for keratin 19 showed positive reactivity in typical cholangiolocellular carcinoma component but negative reactivity in intermediate component. Both areas showed positive reactivity for EpCAM which is a marker for stem/progenitor cells.</p>
      <p>Cholangiolocellular carcinoma, now cholangiolocellular type of combined hepatocellular-cholangiocarcinoma with stem cell features, was traditionally classified as a special type of intrahepatic cholangiocarcinoma. In the latest classification of WHO digestive system, cholangiolocellular carcinoma was reclassified into combined hepatocellular-cholangiocarcinoma with stem cell features, because this type of tumor shows histologic and immunohistochemical differentiation of hepatic progenitor/stem cells and often shows focal differentiation of hepatocellular carcinoma or intermediate differentiation between hepatocellular carcinoma and cholangiocarcinoma.<xref rid="B1" ref-type="bibr">1</xref><xref rid="B2" ref-type="bibr">2</xref> However, its clinical outcome has not been clarified because of its limited number of cases. There are some reports not only that cholangiolocellular carcinoma has poor outcome as much as intrahepatic cholangiocarcinoma but also that cholangiolocellular carcinoma has favorable long-term survival.<xref rid="B6" ref-type="bibr">6</xref><xref rid="B7" ref-type="bibr">7</xref> There are two studies for clinicopathological analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.<xref rid="B8" ref-type="bibr">8</xref><xref rid="B9" ref-type="bibr">9</xref> But these studies also had limited number of cases (less than 100 patients). So it is required more cases and studies for evaluation of prognosis and treatment strategy in cholangiolocellular carcinoma patients.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p><bold>Conflicts of Interest:</bold> The authors have no conflicts to disclose.</p>
      </fn>
    </fn-group>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>EpCAM</term>
          <def>
            <p>epithelial cell adhesion molecule</p>
          </def>
        </def-item>
        <def-item>
          <term>HepPar-1</term>
          <def>
            <p>hepatocyte paraffin 1</p>
          </def>
        </def-item>
        <def-item>
          <term>WHO</term>
          <def>
            <p>World Health Organization</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Steiner</surname>
              <given-names>PE</given-names>
            </name>
            <name>
              <surname>Higginson</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Cholangiolocellular carcinoma of the liver</article-title>
          <source>Cancer</source>
          <year>1959</year>
          <volume>12</volume>
          <fpage>753</fpage>
          <lpage>759</lpage>
          <pub-id pub-id-type="pmid">13663020</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Theise</surname>
              <given-names>ND</given-names>
            </name>
            <name>
              <surname>Saxena</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Portmann</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Thung</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Yee</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Chiriboga</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The canals of Hering and hepatic stem cells in humans</article-title>
          <source>Hepatology</source>
          <year>1999</year>
          <volume>30</volume>
          <fpage>1425</fpage>
          <lpage>1433</lpage>
          <pub-id pub-id-type="pmid">10573521</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Bosman</surname>
              <given-names>FT</given-names>
            </name>
            <name>
              <surname>Carneiro</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hruban</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Theise</surname>
              <given-names>ND</given-names>
            </name>
          </person-group>
          <source>WHO classification of tumours of the digestive system</source>
          <edition>4th ed</edition>
          <publisher-loc>Lyon</publisher-loc>
          <publisher-name>International Agency for Research on Cancer</publisher-name>
          <year>2010</year>
          <fpage>1</fpage>
          <lpage>417</lpage>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>YB</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype</article-title>
          <source>J Hepatol</source>
          <year>2004</year>
          <volume>40</volume>
          <fpage>298</fpage>
          <lpage>304</lpage>
          <pub-id pub-id-type="pmid">14739102</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Komuta</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Spee</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Vander Borght</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>De Vos</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Verslype</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Aerts</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin</article-title>
          <source>Hepatology</source>
          <year>2008</year>
          <volume>47</volume>
          <fpage>1544</fpage>
          <lpage>1556</lpage>
          <pub-id pub-id-type="pmid">18393293</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maeda</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hashimoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ishida</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yamashita</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Saeki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kawanaka</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Repeat hepatectomy for intrahepatic recurrence of cholangiolocellular carcinoma</article-title>
          <source>Fukuoka Igaku Zasshi</source>
          <year>2013</year>
          <volume>104</volume>
          <fpage>564</fpage>
          <lpage>568</lpage>
          <pub-id pub-id-type="pmid">24693685</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ariizumi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kotera</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Katagiri</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nakano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nakanuma</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Long-term survival of patients with cholangiolocellular carcinoma after curative hepatectomy</article-title>
          <source>Ann Surg Oncol</source>
          <year>2014</year>
          <volume>21</volume>
          <issue>Suppl 3</issue>
          <fpage>S451</fpage>
          <lpage>S458</lpage>
          <pub-id pub-id-type="pmid">24633664</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sasaki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kakuda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Nakanuma</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Clinicopathological significance of 'subtypes with stem-cell feature' in combined hepatocellular-cholangiocarcinoma</article-title>
          <source>Liver Int</source>
          <year>2015</year>
          <volume>35</volume>
          <fpage>1024</fpage>
          <lpage>1035</lpage>
          <pub-id pub-id-type="pmid">24712771</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akiba</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Nakashima</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Hattori</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tanikawa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Takenaka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nakayama</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification</article-title>
          <source>Am J Surg Pathol</source>
          <year>2013</year>
          <volume>37</volume>
          <fpage>496</fpage>
          <lpage>505</lpage>
          <pub-id pub-id-type="pmid">23388123</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <title>Macroscopic picture of the right lobe of the liver. 5 cm-sized whitish firm and fibrotic mass with multiple small satellite nodules.</title>
      </caption>
      <graphic xlink:href="cmh-21-183-g001"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <title>Histologic features of combined hepatocellular-cholangiocarcinoma. (A) Typical cholangiolocellular carcinoma component with tumor cells arranged in tubular and "antler-like" pattern in a markedly fibrous stroma. (B) Satellite nodule showing intermediate differentiation. Tumor cells show more abundant cytoplasm, structural pattern of trabeculae or nest, and scant fibrous stroma (Hematoxylin and eosin, &#xD7;200).</title>
      </caption>
      <graphic xlink:href="cmh-21-183-g002"/>
    </fig>
    <fig id="F3" orientation="portrait" position="float">
      <label>Figure 3</label>
      <caption>
        <title>Immunohistochemical findings of typical cholangiolocellular carcinoma component (left column) and intermediate differentiation component (right column). Typical cholangiolocellular carcinoma component shows negativity for HepPar-1 (A) and positive reactivity for keratin 19 (B) and EpCAM (C). Intermediate differentiation component shows negative reactivity for HepPar-1 (D) and keratin 19 (E), and weak positive reactivity for Ep-CAM (F). EpCAM, epithelial cell adhesion molecule; HepPar-1, hepatocyte paraffin 1.</title>
      </caption>
      <graphic xlink:href="cmh-21-183-g003"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
